高级检索
当前位置: 首页 > 详情页

Exosomal long non-coding RNA LIPCAR derived from oxLDL-treated THP-1 cells regulates the proliferation of human umbilical vein endothelial cells and human vascular smooth muscle cells

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Hubei Univ Med, Taihe Hosp, Dept Cardiothorac Surg, Shiyan 442000, Hubei, Peoples R China [2]Huazhong Univ Sci & Technol, Dept Anat, Tongji Med Coll, Wuhan 430030, Peoples R China [3]Huazhong Univ Sci & Technol, Cent Hosp Wuhan, Dept Cardiothorac Surg, Tongji Med Coll, Wuhan 430030, Hubei, Peoples R China [4]Huazhong Univ Sci & Technol,Tongji Hosp,Dept Cardiothorac & Vasc Surg,Tongji Med Coll,1095 Jiefang Ave,Wuhan 430030,Hubei,Peoples R China [5]Minist Educ, Key Lab Organ Transplantat, Wuhan 430030, Peoples R China
出处:
ISSN:

关键词: Atherosclerosis lncRNA LIPCAR Knockdown Exosome Foam cell

摘要:
Background: It has been reported that long non-coding RNA (lncRNA) LIPCAR is involved in the progression of atherosclerosis. However, the mechanism underlying the effects of LIPCAR on regulating the occurrence and development of atherosclerosis remains unclear. Methods: Reverse transcription-quantitative PCR was performed to detect the levels of LIPCAR in the plasma of patients with atherosclerosis and in THP-1 macrophages. THP-1 cells were stimulated with oxidized low-density lipoprotein (ox-LDL) to induce foam cell formation. Furthermore, Transwell assay was carried out to evaluate the migration ability of vascular smooth muscle cells (VSMCs). Results: The expression of LIPCAR in the plasma of patients with atherosclerosis was significantly higher compared with that in healthy subjects, while LIPCAR knockdown notably reversed ox-LDL-induced THP1 cell apoptosis. In addition, LIPCAR was upregulated in exosomes derived from THP-1 cells treated with ox-LDL (THP-1/ox-LDL Exo). Furthermore, THP-1/ox-LDL Exo significantly increased the expression levels of CDK2 and proliferative cell nuclear antigen in human VSMCs, while these effects were reversed following LIPCAR silencing. Conclusion: The results of the present study suggested that exosomal lncRNA LIPCAR derived from oxLDL modified THP-1 cells could promote the progression of atherosclerosis. Therefore, LIPCAR may be considered as a novel biomarker for the development of new strategies to treat atherosclerosis. (c) 2021 Elsevier Inc. All rights reserved.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 3 区 生物
小类 | 3 区 生物物理 4 区 生化与分子生物学
最新[2025]版:
大类 | 4 区 生物学
小类 | 4 区 生化与分子生物学 4 区 生物物理
JCR分区:
出版当年[2019]版:
Q2 BIOPHYSICS Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY
最新[2023]版:
Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY Q3 BIOPHYSICS

影响因子: 最新[2023版] 最新五年平均 出版当年[2019版] 出版当年五年平均 出版前一年[2018版] 出版后一年[2020版]

第一作者:
第一作者单位: [1]Hubei Univ Med, Taihe Hosp, Dept Cardiothorac Surg, Shiyan 442000, Hubei, Peoples R China
通讯作者:
通讯机构: [4]Huazhong Univ Sci & Technol,Tongji Hosp,Dept Cardiothorac & Vasc Surg,Tongji Med Coll,1095 Jiefang Ave,Wuhan 430030,Hubei,Peoples R China [5]Minist Educ, Key Lab Organ Transplantat, Wuhan 430030, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:434 今日访问量:0 总访问量:419 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)